Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 224 participants.

Also called NCT04767022

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 224 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04767022
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04767022. Randomized; double masking; primary purpose treatment. Start 2021-01-30 (actual); primary completion 2023-12-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR
Intervention (Device)
Paclitaxel Coated PTCA Balloon Catheter(Genoss® DCB)
Intervention (Device)
Paclitaxel Coated PTCA Balloon Catheter(SeQuent® Please NEO)
Lead sponsor
Genoss Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04767022
Content hash
f2a844960bd400ecaa9bcbeba094e63f66250e12dfdeef9851ce29d9041a795e